학술논문
Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia June 2022 22(6):373-381
Subject
Language
ISSN
2152-2650